Valentina Ceni

Valentina Ceni

Auto-generated profile, based on publicly available information

Valentina Ceni

Department of Gynecology and Obstetrics, University of Parma, 43126 Parma, Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Cancer Treatment Reviews
Verified
Journal Article
Closed access
Domenica LorussoDomenica Lorusso
Domenica Lorusso
VCValentina Ceni
Valentina Ceni
GDGennaro Daniele
Gennaro Daniele
VSVanda Salutari
Vanda Salutari
APAntonella Pietragalla
Antonella Pietragalla
GSGiovanni Scambia
Giovanni Scambia

28 February 2021 in Exploration of Targeted Anti-tumor Therapy
Verified
Journal Article
Open access
PDF file
Domenica LorussoDomenica Lorusso
Domenica Lorusso
VCValentina Ceni
Valentina Ceni
GDGennaro Daniele
Gennaro Daniele
APAntonella Pietragalla
Antonella Pietragalla
VSVanda Salutari
Vanda Salutari
GSGiovanni Scambia
Giovanni Scambia
Immunotherapy has changed the natural history of several malignancies that, a decade ago, had a very poor prognosis, such as lung cancer and melanoma. Consequently, many attempts have been done to expand the indications of immunotherapy agents, predominantly immune checkpoint inhibitors (ICIs), in other cancers, including gynecological malignancies. Alongside promising results in cervical and endometrial neoplasms, there are not clear data on the benefit of ICIs as single agent or in combination with antiangiogenic agents in ovarian cancer (OC) and ongoing trials are focusing on combining ICIs with standard chemotherapy or PARP inhibitors. This chapter summarized the evidences of ICIs in gynecological malignancies and report the ongoing trials in cervical, endometrial and OC.